89 related articles for article (PubMed ID: 23535553)
41. [Familial clustering, genetic roots and insights into the pathogenesis of autoimmune diseases].
Pierer M; Baerwald C; Wagner U
Z Rheumatol; 2009 Nov; 68(9):758-62. PubMed ID: 19838714
[TBL] [Abstract][Full Text] [Related]
42. [Molecular tests for (early) recognition of endocrine disorders - towards a sophisticated management of complex endocrine and metabolic diseases].
Kopp P
Ther Umsch; 2010 Jul; 67(7):367-73. PubMed ID: 20577965
[TBL] [Abstract][Full Text] [Related]
43. [Molecular analyses for (early) recognition of hematologic diseases - sense and sensibility for molecular analysis: the art of intelligent decision-making].
Baerlocher GM; Oppliger Leibundgut E
Ther Umsch; 2010 Jul; 67(7):349-58. PubMed ID: 20577963
[TBL] [Abstract][Full Text] [Related]
44. [Not Available].
Menter T; Tzankov A; Dirnhofer S
Ther Umsch; 2017 Sep; 74(4):197-203. PubMed ID: 28950777
[No Abstract] [Full Text] [Related]
45. A survey of the current clinical facilities for the management of familial cancer in Europe. European Union BIOMED II Demonstration Project: Familial Breast Cancer: audit of a new development in medical practice in European centres.
Hodgson SV; Haites NE; Caligo M; Chang-Claude J; Eccles D; Evans G; Møller P; Morrison P; Steel CM; Stoppa-Lyonnet D; Vasen H
J Med Genet; 2000 Aug; 37(8):605-7. PubMed ID: 10922389
[No Abstract] [Full Text] [Related]
46. Panel Testing Is Not a Panacea.
Axilbund JE
J Clin Oncol; 2016 May; 34(13):1433-5. PubMed ID: 26976416
[No Abstract] [Full Text] [Related]
47. 23andMe and Me.
Lietz CM
Narrat Inq Bioeth; 2015; 5(3):212-4. PubMed ID: 26752570
[No Abstract] [Full Text] [Related]
48. Health screening tests: a note of caution.
Murphy JF
Ir Med J; 2005 Sep; 98(8):228. PubMed ID: 16255110
[No Abstract] [Full Text] [Related]
49. Quantifying the health benefits of genetic tests: a clinical perspective.
Scheuner MT; Rotter JI
Genet Med; 2006 Mar; 8(3):141-2. PubMed ID: 16540747
[No Abstract] [Full Text] [Related]
50. Genetic testing.
Howell VM; Burnett L
Lancet; 1996 Mar; 347(9002):685-6. PubMed ID: 8596394
[No Abstract] [Full Text] [Related]
51. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
52. [Genetic test and prophylactic treatment in breast cancer families].
Miyoshi Y; Noguchi S
Gan To Kagaku Ryoho; 2002 Apr; 29(4):512-22. PubMed ID: 11977534
[TBL] [Abstract][Full Text] [Related]
53. [New genetic tests and their clinical utility for cancer screening].
Probst-Hensch NM; Brand A
Ther Umsch; 2013 Apr; 70(4):251-4; discussion 255-6. PubMed ID: 23535553
[TBL] [Abstract][Full Text] [Related]
54. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
Joosse SA; Brandwijk KI; Devilee P; Wesseling J; Hogervorst FB; Verhoef S; Nederlof PM
Breast Cancer Res Treat; 2012 Apr; 132(2):379-89. PubMed ID: 20614180
[TBL] [Abstract][Full Text] [Related]
55. Preventive surgery is associated with reduced cancer risk and mortality in women with BRCA1 and BRCA2 mutations.
Domchek SM; Rebbeck TR
LDI Issue Brief; 2010; 16(2):1-4. PubMed ID: 21545057
[TBL] [Abstract][Full Text] [Related]
56. Strategies for ovarian cancer prevention.
Dann RB; Kelley JL; Zorn KK
Obstet Gynecol Clin North Am; 2007 Dec; 34(4):667-86, viii. PubMed ID: 18061863
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
